title: [Treatment of myeloma when high dose therapy is not possible. New drugs--alternatives for elderly patients].
authors.affiliation: Radiumhemmet, Karolinska universitetssjukhuset, Solna. hakan.mellstedt@karolinska.se
authors.forename: Håkan
authors.initials: H
authors.lastname: Mellstedt
authors.forename: Peter
authors.initials: P
authors.lastname: Gimsing
authors.forename: Anders
authors.initials: A
authors.lastname: Waage
mesh_terms: D000367:Age Factors; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D001897:Boronic Acids / Q000009:adverse effects / Q000627:therapeutic use; D000069286:Bortezomib; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D000077269:Lenalidomide; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000401:mortality; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D017410:Practice Guidelines as Topic; D011480:Protease Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D011719:Pyrazines / Q000009:adverse effects / Q000627:therapeutic use; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D007166:Immunosuppressive Agents; D011480:Protease Inhibitors; D011719:Pyrazines; D013792:Thalidomide; D000069286:Bortezomib; D000077269:Lenalidomide